Europe Neurostimulation Devices Market

Europe Neurostimulation Devices Market Size

The size of the Europe neurostimulation devices market was valued at USD 4.83 billion in 2024. This market is expected to grow at a CAGR of 6.38% from 2025 to 2033 and be worth USD 18.80 billion by 2033 from USD 5.62 billion in 2025. 

MARKET DRIVERS

Growing Aging Population, Neurological Disorders, and R&D Investments Fuel Europe's Neurostimulation Market

The aging population and increased prevalence of neurological disorders, increased demand for minimally invasive operations, and technological advancements drive the European neurostimulation market forward. Instead, research on the application of neurostimulators in disease management, such as obsessive-compulsive disorders, interstitial cystitis, and asthma, is ongoing. It is projected to generate economic prospects in future years to grow the market for neurostimulators. Increased prevalence of lifestyle diseases, including depression and chronic pain, as well as an increase in the number of neurological illnesses and investment in R&D, are driving the market for European neurostimulation devices to expand.

The adoption rate of these gadgets in the market is expected to increase as new technologies for restoring vision and assisting movement in paralysis become available. Technological advancements, such as the nervous system stimulator device, allow patients to treat various nerve disorders, accelerating the expansion of the neurostimulation device industry. As a result, neurostimulation is commonly employed in minimally invasive surgical procedures. The European Neurostimulation devices market is predicted to increase significantly as a result of this.

MARKET RESTRAINTS

Allergic Reactions, Alternative Therapies, and Regulatory Delays Restrain Europe’s Neurostimulation Devices Market

Adverse effects such as allergic reactions or tingling or prickling of the skin are predicted to limit European neurostimulation devices' market expansion and costs. In addition, the market's growth is limited by the availability of various therapeutic choices such as pharmaceutical treatments and surgical operations. Neurostimulation risks and the availability of other treatment alternatives for neurological disorders are some of the negative factors that are anticipated to hinder market expansion. The major challenges faced by companies involved in the production of neurological devices are the delay in regulatory approvals and the high cost of interventional devices.

REGIONAL ANALYSIS

The European market accounted for a significant share of the global neurostimulation devices market in 2024. The expansion is predicted to be aided by fast economic development and enhanced technical usage. The market in Europe is growing due to a rise in the number of people affected by chronic pain and increased public awareness and coverage of neurostimulation devices. Because of the increased preference for new technologies and innovations, the neurostimulation devices market in Europe is likely to rise at a rapid pace during the forecast period. Furthermore, compared to drug therapy, the clinical evidence for neurostimulation devices is expected to grow with time. Over the upcoming years, Germany is expected to increase at the fastest rate. Depression among teenagers is on the rise. According to a German health insurance firm, around 480,000 German students suffer from mental disorders. This has resulted in an increase in medical expenses for the treatment of various disorders, presenting an attractive potential for the neurostimulation device market to expand. The high prevalence of Alzheimer's disease in Spain is expected to increase the demand for neurostimulation devices. The country is attempting to enhance the patients' overall quality of life.

KEY MARKET PLAYERS

Companies dominating the European neurostimulation devices market profiled in this report are Abbott Laboratories, Aleva Neurotherapeutics SA, Boston Scientific Corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, Nevro Corporation, Neuronetics Inc., NeuroSigma, Inc., and Synapse Biomedical Inc.

MARKET SEGMENTATION

This Europe neurostimulation devices market research report is segmented and sub-segmented into the following categories.

By Technology

• Internal
• External

By Application

• Spinal Cord Stimulation
• Deep Brain Stimulation
• Sacral Nerve Stimulation
• Gastric Electrical Stimulation
• Transcutaneous Electrical Nerve Stimulation
• Transcranial Magnetic Stimulation
• Respiratory Electrical Stimulation

By Country

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe